Shots: The first patient has been dosed in P-l/ll adaptive-design study assessing the safety, tolerability, pharmacokinetics, and antitumor activity of LNS8801+ Keytruda (pembrolizumab) in patients who had previous clinical benefit […]readmore
Tags : First Patients Dosing
Shots: The company has reported the first patient dosing in the P-I CALOSOMA study assessing the safety, tolerability, PK/PD of GLPG3970 single & multiple ascending doses in up to 52 […]readmore
Shots: The first patient has been dosed in the P-II AAVIATE trial to assess the suprachoroidal delivery of RGX-314 (2.5×1011 GC/eye & 5×1011 GC/eye) vs ranibizumab (0.5mg, monthly, IVT) using […]readmore